1. A Multicenter, Phase I/II Study of Sequential Epigenetic and Immune Targeting in Combination with Nab-Paclitaxel/Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma. Available Online: 〈https://Clinicaltrials.Gov/Ct2/Show/NCT04257448〉 Accessed on 21 January 2023.
2. A Phase 2 Clinical Trial of Entinostat in Combination with Nivolumab for Patients with Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma. Available Online: 〈https://Clinicaltrials.Gov/Ct2/Show/NCT03250273〉 Accessed on 21 January 2023.
3. A Phase I/II Study of Romidepsin (Depsipeptide) in Combination with Gemcitabine in Patients with Pancreatic and Other Advanced Solid Tumors. Available Online: 〈https://Clinicaltrials.Gov/Ct2/Show/NCT00379639〉 Accessed on 21 January 2023.
4. A Phase IB Trial with OTX015/MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Patients with Selected Advanced Solid Tumors. Available Online: 〈https://Clinicaltrials.Gov/Ct2/Show/NCT02259114〉 Accessed on 21 January 2023.
5. The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia;Abou Dalle;Therapeutic Advances in Hematology,2018